The Explosive Demand for Medical Weight Loss Services
The introduction of GLP-1 receptor agonists like semaglutide and tirzepatide has created an unprecedented demand for medical weight loss services. Patients who previously had limited options for medically supervised weight management now have access to medications that produce 15–25% body weight reduction — and they’re actively seeking licensed practitioners to prescribe and monitor them. For practitioners, this represents a massive clinical and business opportunity.
Defining Your Clinical Scope
A telehealth metabolic clinic can range from a lean GLP-1 prescribing service to a comprehensive metabolic health program incorporating nutrition, behavioral support, exercise prescription, and hormone optimization. Define your scope clearly — and ensure it’s within your clinical training and licensure. Practitioners with additional training in endocrinology, obesity medicine, or functional medicine are best positioned for comprehensive programs.
Credentialing and Certification
Consider pursuing board certification through the American Board of Obesity Medicine (ABOM). The ABOM certification is increasingly recognized by patients as a mark of expertise in weight management and signals commitment to the field. Even without board certification, completing obesity medicine CME courses significantly strengthens your clinical knowledge and marketing positioning.
Clinical Intake Process
A thorough intake for metabolic patients includes: BMI and waist circumference, complete metabolic history, previous weight loss attempts, current medications, relevant comorbidities, labs (fasting glucose, HbA1c, fasting insulin, lipid panel, thyroid panel, CBC, CMP, and hormone panel if indicated), and an assessment of psychological relationship with food. Many metabolic issues have hormonal underpinnings — don’t miss a hypothyroid or cortisol-driven obesity case.
GLP-1 Prescription and Compounding Considerations
Brand-name semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) are the FDA-approved options. During periods of shortage, compounded semaglutide has been widely prescribed. Understand current FDA guidance on compounding restrictions for these medications, as the regulatory landscape evolves. Partnering with a reputable 503A compounding pharmacy and maintaining clear documentation protects your practice.
Patient Follow-Up and Long-Term Care
Weight management is long-term medicine. Build a follow-up protocol that includes monthly check-ins during active titration, quarterly visits during maintenance, and annual comprehensive metabolic reassessment. Integrate behavioral health support — either through in-house resources or referral partnerships. Patients who receive behavioral support alongside medication lose more weight and maintain results better.